Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL534268 | 0.84 | TSHR (0.42) | TSHR | |
| SCHEMBL8558513 | 0.79 | — | — | |
| SCHEMBL7370103 | 0.77 | — | — | |
| SCHEMBL20486967 | 0.77 | — | — | |
| SCHEMBL5402636 | 0.77 | — | — | |
| SCHEMBL9529779 | 0.77 | — | — | |
| SCHEMBL28383052 | 0.77 | — | — | |
| SCHEMBL20486905 | 0.77 | TSHR (0.33) | TSHR | |
| SCHEMBL9201518 | 0.77 | — | — | |
| SCHEMBL9816151 | 0.75 | TSHR (0.67) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1686 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116854683-A | Coumarin thiazole derivative and preparation method and application thereof | 中北大学 | 2023-10-10 | — | — | CN | claimed |
| CN-114105993-B | Synthesis method of chiral pyrroloimidazole compound | 大连理工大学 | 2023-03-10 | — | — | CN | claimed |
| CN-114105993-A | Synthesis method of chiral pyrroloimidazole compound | 大连理工大学 | 2022-03-01 | — | — | CN | claimed |
| CN-109942553-B | Synthesis and conversion method of chiral 3,4, 6-trisubstituted tetrahydro 2H-pyran-2-one compound | 大连理工大学 | 2020-09-29 | — | — | CN | claimed |
| CN-109942553-A | A kind of synthesis of tri- substituted-tetrahydro 2H- pyran-2-one compound of chirality 3,4,6- and its method for transformation | 大连理工大学 | 2019-06-28 | — | — | CN | claimed |
| EP-3197507-A1 | MALODOR REDUCTION COMPOSITIONS | The Procter and Gamble Company (US) | 2017-08-02 | — | — | EP | claimed |
| WO-2016049389-A1 | MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| EP-2415763-B1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING GLAUCOMA | UBE INDUSTRIES (JP) | 2016-01-27 | — | — | EP | claimed |
| US-20140113907-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | UBE INDUSTRIES, LTD. (JP) | 2014-04-24 | — | — | US | claimed |
| EP-2520570-A1 | AMINOPYRIDINE COMPOUND | Ube Industries, Ltd. (JP) | 2012-11-07 | — | — | EP | claimed |
| EP-0641786-B1 | Process for producing optically active alcohol | SUMITOMO CHEMICAL CO (JP) | 1997-08-20 | — | — | EP | claimed |
| EP-0639556-B1 | Process for the preparation of trifluoromethylanilines | HOECHST AG (DE) | 1997-03-05 | — | — | EP | claimed |
| EP-0641786-A1 | Process for producing optically active alcohol | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-03-08 | — | — | EP | claimed |
| US-5144039-A | Reducing prochiral ketone with metal borohydride modified with optically active amino alcohol in presence of ether or sulfide | SUMITOMO ELECTRIC COMPANY, LIMITED (JP) | 1992-09-01 | — | — | US | claimed |
| EP-0381434-A1 | Process for producing optically active alcohol | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-08-08 | — | — | EP | claimed |
| EP-0161480-B1 | N-IODINE PROPARGYL-CHLOROMETHANESULFONAMIDE | BAYER AG (DE) | 1987-06-03 | — | — | EP | claimed |
| EP-0161480-A1 | N-iodine propargyl-chloromethanesulfonamide | BAYER AG (DE) | 1985-11-21 | — | — | EP | claimed |
| EP-0062773-B1 | 4-Phenyl-1,2,3-thiadiazoles as herbicide extenders | STAUFFER CHEMICAL COMPANY (US) | 1984-12-05 | — | — | EP | claimed |
| EP-0062773-A1 | 4-Phenyl-1,2,3-thiadiazoles as herbicide extenders | STAUFFER CHEMICAL COMPANY (US) | 1982-10-20 | — | — | EP | claimed |
| US-4215129-A | 2-(2,4-DICHLOROPHENYL)-5-ARYL-1,3,4-OXADIAZOLE | THE DOW CHEMICAL COMPANY (US) | 1980-07-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140113907-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | PTGER2, PTGER1, PTGDR2 | TSHR 987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.